Correction: Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis.

Panda LP, Barhwal K, Kumar A, Biswal S, Tripathy DK, Sable MN, Sahu RN, Chhabra G

DOI: 10.3389/fonc.2026.2021223
Published: 2026
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.2021223,
  title = {Correction: Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis.},
  author = {Panda LP and Barhwal K and Kumar A and Biswal S and Tripathy DK and Sable MN and Sahu RN and Chhabra G},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.2021223},
  url = {https://doi.org/10.3389/fonc.2026.2021223}
}

RIS

TY  - JOUR
TI  - Correction: Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis.
AU  - Panda LP
AU  - Barhwal K
AU  - Kumar A
AU  - Biswal S
AU  - Tripathy DK
AU  - Sable MN
AU  - Sahu RN
AU  - Chhabra G
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.2021223
UR  - https://doi.org/10.3389/fonc.2026.2021223
ER  -

APA

LP, P., K, B., A, K., S, B., DK, T., MN, S., RN, S., & G, C. (2026). Correction: Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.2021223

Source records

pubmed · retrieved 2026-11-10T14:55:04.619Z